Quality control criteria in the surgical management of advanced ovarian cancers;Critères de « qualité » dans la prise en charge des cancers de l'ovaire au stade avancé

Bulletin du Cancer

Volumn 96, Issue 12, 2009, Pages 1255-1262

  Querleu, D ^a   Narducci, F ^b  

^a INSTITUT CLAUDIUS REGAUD   (France)

^b CENTRE OSCAR LAMBRET   (France)

Author keywords

Ovarian cancer; Quality control; Surgery

Indexed keywords

ADVANCED CANCER; CANCER STAGING; CANCER SURGERY; CLINICAL PRACTICE; CYTOREDUCTIVE SURGERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MEDICAL SPECIALIST; OVARY CARCINOMA; PATIENT SELECTION; PREOPERATIVE CARE; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SURGEON; TREATMENT OUTCOME; ANESTHESIOLOGY; CANCER CENTER; CLINICAL COMPETENCE; FEMALE; GENERAL SURGERY; GYNECOLOGY; MEDICAL AUDIT; ONCOLOGY; ORGANIZATION AND MANAGEMENT; OVARY TUMOR; STANDARD;

ANESTHESIOLOGY; CANCER CARE FACILITIES; CLINICAL COMPETENCE; FEMALE; GENERAL SURGERY; GYNECOLOGY; HUMANS; MEDICAL AUDIT; MEDICAL ONCOLOGY; OVARIAN NEOPLASMS; PATIENT SELECTION; PREOPERATIVE CARE; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL;

EID: 74049152307     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2009.0990     Document Type: Review

References (26)

1. Querleu D, Bonnier P, Morice P, Narducci F. Prise en charge initiale des cancers gynécologiques : recommandations de la Société française d'oncologie gynécologique. Gynecol Obstet Fert 2008 ; 36 : 338-52.
2. Standards, options, recommandations. www.sor-cancer.fr.
3. Geisler JP, Linnemeier GC, Thomas AJ, Manahan KJ. Nutritional assessment using prealbumin as an objective criterion to determine whom should not undergo primary radical cytoreductive surgery for ovarian cancer. Gynecol Oncol 2007 ; 106 : 128-31.
4. Munstedt K, von Georgi R, Zygmunt M, Missewitz B, Stillger R, Kunzel W. Shortcomings and deficits in surgical treatment of gynecologic cancers: a German problem only? Gynecol Oncol 2002 ; 86 : 337-43.
5. Querleu D, Ferron G, Gladieff L. Vers une évolution du dogme de la chirurgie optimale dans les cancers de l'ovaire. Bull Cancer 2009 (in press).
6. Vernooij F, Heintz P, Witteveen E, van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 2007 ; 105 : 801-12.
7. Zivanovic O, Aldini A, Carlson JW, Chi DS. Advanced cytoreductive surgery: American perspective. Gynecologic Oncology 2009 ; 114 : S3-9.
8. Rafii A, Jean-Laurent M, Morice P, Houvenaeghel G, Lecuru F, Leblanc E, et al. Morbidity and mortality of advanced ovarian cancer debulking surgery in 6 French cancer centers. ESGO meeting, Belgrade, 2009.
9. Eisenhauer EL, D'Angelica MI, Abu-Rustum NR, Sonoda Y, Jarnagin WR, Barakat RR, et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced Mullerian cancer. Gynecol Oncol 2006 ; 103 : 871-7.
10. Swellengrebel HA, Zoetmulder FA, Smeenk RM, Antonini N, Verwaal VJ. Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic tools. Eur J Surg Oncol 2009. [Epub ahead of print].
11. Nguyen HN, Averette HE, Hoskins W, Penalver M, Sevin BU, Steren A. National survey of ovarian carcinoma part V. The impact of physician's specialty on patients' survival. Cancer 1993 ; 72 : 3663-70.
12. Elit L, Bondy SJ, Paszat L, Przybysz R, Levine M. Outcome in surgery for ovarian cancer. Gynecol Oncol 2002 ; 87 : 26-7.
13. Marth C, Hiebl S, OberaignerW,Winter R, Leodolter S, Sevelda P. Influence of department volume on survival for ovarian cancer: results from a prospective quality assurance program of the Austrian Association for Gynecologic Oncology. Int J Gynecol Cancer 2009 ; 19 : 94-102.
14. Kumpulainen S, Grenman S, Kyyronen P, Pukkala W, Sankila R. Evidence of benefit from centralised treatment of ovarian cancer: a nationwide population survival analysis in Finland. Int J Cancer 2002 ; 102 : 541-4.
15. Du Bois A, Rochon J, Pfisterer J, Hoskins W. Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: as systematic review. Gynecol Oncol 2008 ; 112 : 422-36.
16. Arain MR, Buggy DJ. Anaesthesia for cancer patients. Curr Opion Anaesthesiol 2007 ; 20 : 247-53.
17. du Bois A, Rochon J, Lamparter C, Pfisterer J. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer 2005 ; 15 : 183-91.
18. RobinsonWR, Ritter J, Rogers AS, Tedjarati S, Lieberenz C. Clinical trial participation is associated with improved outcome in women with ovarian cancer. Int J Gynecol Cancer 2009 ; 19 : 124-8.
19. Verleye L, Ottevanger PB, Vergote I. Surgical program building in advanced ovarian cancer: European perspective. Gynecol Oncol 2009 ; 114 : S10-4.
20. Kommoss H, Traut A, Strutas D, Riegler N, Buhrmann C, Gomez R, et al. Compliance to consensus recommendations, surgeon's experience, and introduction of a quality insurance and management program. Influence on therapy of early-stage ovarian carcinoma. Int J Gynecol Cancer 2009 ; 19 : 787-93.
21. Aletti GD, Santillan A, Eisenhauer EL, et al. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a riskadjusted model. Gynecologic Oncology 2007 ; 107 : 99-106.
22. Crandon AJ, Obermair A. Advanced cytoreductive surgery: Asia Pacific perspective. Gynecol Oncol 2009 ; 114 : S15-21.
23. Guidance on Commissioning Cancer Services. Improving outcomes in gynaecological cancers. The Manual, NHS.
24. Paulsen T, Kjaerheim K, Kaern J, Tretli S, Tropé C. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer 2006 ; 16 (suppl 1) : 11-7.
25. IARC. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide (2002 estimates). (http://www-dep.iarc.fr/).
26. Verleye L, Ottevanger P, van der Graaf W, Reed N, Vergote I, Gynaecological Cancer Group (GCG) of the European Organisation for Research and Treatment of Cancer (EORTC). EORTC-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer 2009 ; 45 : 517-26.